The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
Favorite
2018
This online fact sheet provides information about HIV/AIDS and TB co-infection.
Favorite
2018
In this 90-minute webinar, a laboratorian and a clinician from the California Department of Public Health provide information on how to best utilize Xpert MTB/RIF testing. The speakers discuss the manufacturer's rules, share issues in the interpretation of test results, and offer expert opinion on how to address these issues.
Favorite
Lab Personnel
2018
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2018
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, including the importance of medication adherence.
Favorite
2018
Basics of MDR-TB Clinical Care: Online Video Series is comprised of a series of short, online lectures presented in easy to digest segments. The series will cover major topics pertaining to epidemiology, diagnosis, treatment regimens, monitoring and case management, side-effects, prevention and isolation, treatment of contacts, and special situations...
Favorite
Civil Surgeons
Health Educators/Communicators
Infection Control and Occupational Health Workers
Lab Personnel
Long-term Residential Care Providers
Managers and Supervisors
Outreach Workers
2017
This online course is designed to provide TB control staff, clinicians, and nurses a brief overview of basic principles of molecular technology and test platforms used for molecular testing of Mycobacterium tuberculosis as a basis for understanding how mutations are associated with drug resistance and what reporting language might be used to describe resistance results.
Favorite
Lab Personnel
2017
This document describes the steps necessary to measure the corrected QT (QTc) interval from electrocardiography (ECG) monitoring for patients being treated either with the shorter treatment regimen or the new drugs for drug-resistant TB treatment.
Favorite
2017
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2017
This manual is a joint publication of the Curry International TB Center and the Tuberculosis Control Branch of the California Department of Public Health. The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.
Favorite
2016
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Favorite
International Agencies
Policy Makers
2016
The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.
Favorite
2016
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2016
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.
Favorite
International Agencies
2016
This material is a collection of 45 examples of the prevention, control, and care of TB. There are examples from 21 countries, including 14 countries of high priority for MDR TB and countries with high and low TB incidence.
Favorite
International Agencies
2016
